Home » Stocks » Tilray

Tilray, Inc. (TLRY)

Stock Price: $5.59 USD -0.27 (-4.61%)
Updated Oct 27, 2020 4:00 PM EDT - Market closed
After-hours: $5.63 +0.04 (0.72%) Oct 27, 7:59 PM

Stock Price Chart

Key Info

Market Cap 710.92M
Revenue (ttm) 200.55M
Net Income (ttm) -521.63M
Shares Out 111.43M
EPS (ttm) -4.73
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 27, 2020
Last Price $5.59
Previous Close $5.86
Change ($) -0.27
Change (%) -4.61%
Day's Open 5.96
Day's Range 5.56 - 6.03
Day's Volume 5,828,283
52-Week Range 2.43 - 25.69

More Stats

Market Cap 710.92M
Enterprise Value 1.05B
Earnings Date (est) Nov 17, 2020
Ex-Dividend Date n/a
Shares Outstanding 111.43M
Float 89.03M
EPS (basic) -4.90
EPS (diluted) -4.73
FCF / Share -2.45
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 23.83M
Short Ratio 3.45
Short % of Float 26.77%
Beta 3.00
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 3.54
PB Ratio 6.92
Revenue 200.55M
Operating Income -383.27M
Net Income -521.63M
Free Cash Flow -305.04M
Net Cash -342.88M
Net Cash / Share -2.70
Gross Margin -11.66%
Operating Margin -191.11%
Profit Margin -260.10%
FCF Margin -152.10%
ROA -15.52%
ROE -212.06%
ROIC -67.50%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (18)

Buy 3
Overweight 0
Hold 14
Underweight 0
Sell 1

Analyst Consensus: Overweight

Price Target

(51.34% upside)
Current: $5.59
Target: 8.46
*Average 12-month price target from 13 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth287.15%110%62.43%-
Gross Profit-23.5014.2811.382.67
Operating Income-300-57.84-7.50-7.05
Net Income-321-67.72-7.81-7.88
Shares Outstanding10083.0175.0075.00
Earnings Per Share-3.20-0.82-0.10-0.11
Operating Cash Flow-258-46.25-6.00-3.32
Capital Expenditures-67.16-49.49-10.89-0.49
Free Cash Flow-325-95.73-16.89-3.81
Cash & Equivalents96.795182.327.53
Total Debt43042951.2228.70
Net Cash / Debt-33388.47-48.89-21.17
Book Value285198-4.852.53
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Tilray, Inc.
Country Canada
Employees 1,646
CEO Brendan Kennedy

Stock Information

Ticker Symbol TLRY
Stock Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Unique Identifier NASDAQ: TLRY
IPO Date July 19, 2018


Tilray engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products to patients, physicians, pharmacies, governments, and hospitals; and for researchers for commercial purposes, as well as compassionate access and clinical research applications. It operates in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, Israel, Ireland, New Zealand, South Africa, Switzerland, the United States, and the United Kingdom. The company was incorporated in 2018 and is headquartered in Nanaimo, Canada.